Davis Polk advised MicroTech Medical, while Clifford Chance has advised the joint sponsors involved in the transaction.The Hangzhou-based firm offers diabetes therapy and manufactures medical devices…
MicroTech Medical’s US$249 Million Initial Public Offering

























